Non-excellent response at 1-year follow-up were associated with preoperative thyroid-stimulating hormone levels, lymph node metastasis, number of metastatic lymph nodes, and first stimulated thyroglobulin. This evidence concerns the gene TG and metastatic malignant neoplasm in the lymph nodes.